Conrad F. Mir – President & CEO, Calmare Therapeutics

Send us Fan MailWhat can kill a promising company before it ever gets the chance to succeed?Conrad F. Mir, President & CEO of Calmare Therapeutics, joins Matt McCoy on The 60 Second Podcast to share one of the first things he looks for when evaluating a company in need of a turnaround: toxic financing.Drawing from firsthand experience, Conrad explains how a company with promising healthcare technology watched a relatively small financing need spiral into a much larger financial burden. His message for founders and executives is simple: understand the true cost of your capital, avoid financing that can become a noose around the business, and make sure you can deliver on the commitments you make.